Recent Price Movement and Market Context
On 8 December 2025, Albert David’s stock recorded an intraday high of Rs.790, representing a 2.96% rise from the previous close, but ultimately settled at the new low of Rs.757.4. This closing price is notably below all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages, signalling sustained weakness in the stock’s price momentum. The stock has declined for four consecutive trading days, accumulating a loss of 4.94% during this period.
In comparison, the Pharmaceuticals & Biotechnology sector outperformed Albert David marginally, with the stock underperforming the sector by 0.28% on the day. Meanwhile, the broader market, represented by the Sensex, experienced a decline of 0.44%, closing at 85,331.56 points after falling 293.28 points from its flat opening. Despite this, the Sensex remains close to its 52-week high, just 0.97% shy of the peak level of 86,159.02, and is trading above its 50-day and 200-day moving averages, indicating a generally bullish market environment contrasting with Albert David’s performance.
Long-Term Price Performance
Over the past year, Albert David’s stock has recorded a return of -44.72%, a stark contrast to the Sensex’s positive 4.43% return over the same period. The stock’s 52-week high was Rs.1,537.2, more than double the current price, underscoring the extent of the decline. This underperformance extends beyond the last year, with the stock lagging behind the BSE500 index over the last three years, one year, and three months, indicating persistent challenges in regaining investor confidence and market traction.
Momentum building strong! This Mid Cap from NBFC is on our MomentumNow radar. Other investors are catching on – will you join?
- - Building momentum strength
- - Investor interest growing
- - Limited time advantage
Financial Performance and Profitability Trends
Albert David’s financial results over recent quarters have reflected ongoing difficulties. The company has reported negative results for four consecutive quarters, with Profit Before Tax excluding other income (PBT LESS OI) at Rs. -0.44 crore, showing a decline of 109.80%. Similarly, the Profit After Tax (PAT) for the quarter stood at Rs. -3.30 crore, down by 118.3%. These figures highlight a contraction in profitability and operational earnings.
Operating cash flow for the year has also been under pressure, registering a low of Rs. -28.44 crore. This negative cash flow position adds to concerns about the company’s ability to generate sufficient internal funds to support its activities. Furthermore, the company’s operating profit has shown a negative annual growth rate of 244.12% over the last five years, indicating a prolonged period of financial strain.
Valuation and Risk Considerations
The stock is currently trading at valuations that are considered risky relative to its historical averages. Over the past year, while the stock has delivered a return of -44.72%, its profits have declined by 122%, reflecting a disconnect between market price and earnings performance. The company’s Earnings Before Interest, Taxes, Depreciation and Amortisation (EBITDA) has been negative, further underscoring the challenges faced in maintaining operational profitability.
Despite these concerns, Albert David maintains a low average debt-to-equity ratio of zero, indicating minimal reliance on external borrowings. The majority shareholding remains with promoters, which may influence the company’s strategic decisions and capital structure.
Why settle for Albert David ? SwitchER evaluates this Pharmaceuticals & Biotechnology micro-cap against peers, other sectors, and market caps to find you superior investment opportunities!
- - Comprehensive evaluation done
- - Superior opportunities identified
- - Smart switching enabled
Sector and Market Position
Albert David operates within the Pharmaceuticals & Biotechnology sector, which has generally shown resilience and growth potential. However, the company’s stock performance has not mirrored the sector’s trends, with the stock underperforming its peers and broader market indices. The sector itself has been supported by positive market sentiment, as evidenced by the Sensex’s proximity to its 52-week high and its bullish moving average positioning.
The divergence between Albert David’s stock trajectory and the sector’s overall performance highlights company-specific factors influencing investor sentiment and valuation. These include the company’s financial results, cash flow challenges, and valuation risks, which have collectively contributed to the stock’s decline to its current 52-week low.
Summary of Key Price and Performance Metrics
To summarise, Albert David’s stock has reached Rs.757.4, its lowest level in the past year, following a four-day losing streak and a near 5% drop in that period. The stock’s 52-week high of Rs.1,537.2 stands in sharp contrast to the current price, reflecting a significant correction. The company’s financial indicators reveal negative profitability trends, declining cash flows, and valuation risks, while the broader market and sector indices have maintained more positive momentum.
These factors collectively provide a comprehensive view of the stock’s recent performance and the challenges it faces within the current market environment.
Limited Time Only! Upgrade now and get 1 Year of Stock of the week worth Rs. 14,999 for FREE. Don't miss out on this exclusive offer. Claim Your Free Year →
